Linda H. Teng

Wellington Road
Clayton, VIC 3800, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Single-Cell Morphomechanics of Prostate Cancer-Associated Fibroblasts Identifies Distinct Features Associated with Patient Outcome.

Single-Cell Morphomechanics of Prostate Cancer-Associated Fibroblasts Identifies Distinct Features Associated with Patient Outcome.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 06, 2025

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants.

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants.

Journal: European urology focus
Published: February 02, 2025

Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor.

Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor.

Journal: BMC cancer
Published: November 11, 2023

Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer.

Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer.

Journal: The Journal of pathology
Published: October 05, 2023

OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer.

OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer.

Journal: Scientific reports
Published: January 18, 2022

Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment.

Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment.

Journal: Cancers
Published: February 18, 2021

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.

Journal: Nature communications
Published: February 15, 2021

Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostate.

Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostate.

Journal: Scientific reports
Published: September 28, 2020

Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.

Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.

Journal: Clinical epigenetics
Published: January 14, 2020

Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro.

Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro.

Journal: Biomaterials
Published: July 10, 2018
Showing 1-10 of 10

Last Updated: 09/26/2026